Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug 30;6(3):38.
doi: 10.3390/brainsci6030038.

Deep Brain Stimulation in Huntington's Disease-Preliminary Evidence on Pathophysiology, Efficacy and Safety

Affiliations
Review

Deep Brain Stimulation in Huntington's Disease-Preliminary Evidence on Pathophysiology, Efficacy and Safety

Lars Wojtecki et al. Brain Sci. .

Abstract

Huntington's disease (HD) is one of the most disabling degenerative movement disorders, as it not only affects the motor system but also leads to cognitive disabilities and psychiatric symptoms. Deep brain stimulation (DBS) of the pallidum is a promising symptomatic treatment targeting the core motor symptom: chorea. This article gives an overview of preliminary evidence on pathophysiology, safety and efficacy of DBS in HD.

Keywords: DBS; Huntington; chorea; deep brain stimulation; globus pallidus; recordings; safety pathophysiology.

PubMed Disclaimer

Conflict of interest statement

Related to Huntington’s Disease and/or deep brain stimulation: L.W. received consultant honoraria and travel grants from Medtronic, St. Jude Medical, Inomed and Desitin. S.J.G. received coverage of travel expenses and honoraria from Medtronic and Boston Scientific. C.J.H., S.E. and S.O. declare no conflicts of interest. A.S. and J.V. received consultant honoraria and travel grants from Medtronic. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Trial NCT02535884 is supported by Medtronic. Medtronic had no role in the design of the review, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results. Medtronic provided Figure 1 for this manuscript on request of the authors.

Figures

Figure 1
Figure 1
DBS components. Subcutaneous implanted impulse generator (IPG), lead extension and stereotactically implanted stimulation electrodes. Image provided by Medtronic.
Figure 2
Figure 2
Basal ganglia network and targets for DBS in HD. Red arrows indicate inhibitory, green arrows indicate excitatory connections.
Figure 3
Figure 3
Stimulated target. Example visualization on 3D coronary MRI-view of individual electrodes and volume of tissue activated (VTA, in red) in relation to the pallidum (in brown). Image source: authors’ own contribution.

References

    1. Hartmann C.J., Groiss S.J., Vesper J., Schnitzler A., Wojtecki L. Brain stimulation in Huntington’s disease. Neurodegener. Dis. Manag. 2016;6:223–236. doi: 10.2217/nmt-2016-0007. - DOI - PubMed
    1. Walker F.O. Huntington’s disease. Semin. Neurol. 2007;27:143–150. doi: 10.1055/s-2007-971176. - DOI - PubMed
    1. Mitchell I.J., Cooper A.J., Griffiths M.R. The selective vulnerability of striatopallidal neurons. Prog. Neurobiol. 1999;59:691–719. doi: 10.1016/S0301-0082(99)00019-2. - DOI - PubMed
    1. Albin R.L., Reiner A., Anderson K.D., Penney J.B., Young A.B. Striatal and nigral neuron subpopulations in rigid huntington’s disease: Implications for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol. 1990;27:357–365. doi: 10.1002/ana.410270403. - DOI - PubMed
    1. Wichmann T., DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 1996;6:751–758. doi: 10.1016/S0959-4388(96)80024-9. - DOI - PubMed

LinkOut - more resources